List of articles in "Drug" category - Page 91

Givinostat (INN) or gavinostat (originally ITF2357) is a histone deacetylase inhibitor with potential anti-inflammatory anti-angiogenic and antineoplastic activities.

Pirnabine (SP-304) is a synthetic cannabinoid receptor ligand which was developed for the treatment of glaucoma.

Naboctate (SP-325) is a synthetic cannabinoid receptor agonist which has antiemetic sedative anxiolytic and anti-glaucoma properties.

Nabazenil (SP-175) is a synthetic cannabinoid receptor agonist which has anticonvulsant properties.

HU-243 (AM-4056) is a synthetic cannabinoid drug that is a single enantiomer of the hydrogenated derivative of the commonly used reference agonist HU-210. It is a potent agonist at both […]

Canbisol (Nabidrox) is a synthetic cannabinoid derivative that is the dimethylheptyl homologue of 9-nor-9β-hydroxyhexahydrocannabinol (HHC). It is a potent agonist at both the CB1 and CB2 receptors with a binding […]

Gabapentin enacarbil (Horizant (in USA) Regnite (in Japan) formerly known as XP-13512) is a prodrug for the anticonvulsant and analgesic drug gabapentin. It was designed for increased oral bioavailability over […]

AEZS-108 (previously AN-152) consists of [D-Lys(6)]LHRH linked to doxorubicin.It is an experimental targeted therapy for various cancers (ovarian endometrial breast bladder prostate) that express LHRH receptor. The U.S. Food and […]

Vemurafenib (INN marketed as Zelboraf) is a B-Raf enzyme inhibitor developed by Plexxikon (now part of the Daiichi Sankyo group) and Genentech for the treatment of late-stage melanoma. The name […]

Carfilzomib (abbreviated CFZ marketed under the trade name Kyprolis Onyx Pharmaceuticals Inc.) is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically it is a tetrapeptide epoxyketone and an […]